Table 2.
Clinicopathological parameters | c-Myc expression | hTERT expression | Relative telomere length | ||||||
---|---|---|---|---|---|---|---|---|---|
Low expression | High expression | p-value | Low expression | High expression | p-value | Short telomeres | Long telomeres | p-value | |
Gender | |||||||||
Males | 08 | 33 | 0.76 | 12 | 29 | 0.3 | 32 | 10 | 0.006 |
Females | 06 | 10 | 07 | 09 | 08 | 07 | |||
Age | |||||||||
≥51 | 12 | 32 | 0.89 | 14 | 30 | 0.03 | 32 | 12 | 0.002 |
≤50 | 01 | 12 | 5 | 8 | 08 | 05 | |||
Smoking status | |||||||||
Smokers | 07 | 26 | 0.3 | 10 | 23 | 0.58 | 26 | 07 | 0.02 |
Nonsmokers | 07 | 17 | 09 | 15 | 14 | 10 | |||
Histopathology | |||||||||
Poorly differentiated | 05 | 18 | 0.18 | 09 | 14 | 0.67 | 16 | 07 | 0.8 |
Moderately differentiated | 06 | 14 | 07 | 13 | 13 | 07 | |||
Well differentiated | 01 | 06 | 02 | 05 | 05 | 02 | |||
Others | 02 | 05 | 01 | 06 | 06 | 01 | |||
TNM staging | |||||||||
Stages I and II | 07 | 14 | 0.0009 | 09 | 15 | 0.01 | 12 | 09 | 0.4 |
Stage III | 07 | 29 | 10 | 23 | 28 | 08 |
The bold values represents that they are statistically significant.